Kura Oncology and Mirati Therapeutics Enter into Clinical Collaboration and Supply Agreement to Evaluate KO-2806 and Adagrasib in KRASᴳ¹²ᶜ-Mutated NSCLC
02 nov. 2023 07h30 HE
|
Kura Oncology, Inc.
SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
[Latest Report] Clinical Communication and Collaboration Market is estimated to be US$ 5.1 billion by 2032; Growing adoption of Digital Technologies to Fuel Market Growth-By PMI
05 sept. 2023 15h30 HE
|
PMI
Covina, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Technological advancement has become major factor in market growth. Further, rising use of smart devices in hospitals has driven target market growth as...
Clinical Communication and Collaboration Market Size to Reach USD 5,029.8 Million By 2027 | Increasing Use of Connected Devices in Hospitals will be the Key Factor Driving the Industry Growth, States Reports and Data
29 janv. 2021 07h11 HE
|
Reports and Data
New York, Jan. 29, 2021 (GLOBE NEWSWIRE) -- The global clinical communication and collaboration market is expected to reach a market size of USD 5,029.8 Million by 2027 and register a significantly...
Global Clinical Communication and Collaboration Market to reach US$ 861.6 Mn by 2025 - Persistence Market Research
25 oct. 2017 07h01 HE
|
Persistence Market Research
New York, Oct. 25, 2017 (GLOBE NEWSWIRE) -- According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry...
Connecticut Children's Medical Center and Harvard Apparatus Regenerative Technology Collaborate to Develop Bioengineered Pediatric Esophageal Solutions
10 août 2015 10h46 HE
|
Connecticut Childrens Medical Center
HARTFORD, Conn., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Connecticut Children's Medical Center has entered into an agreement with Harvard Apparatus Regenerative Technology, Inc., (NASDAQ: HART), or HART, a...